Previous Article | Next Article 
Journal of Virology, August 2000, p. 7119-7126, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Karyophilic Properties of Human
Immunodeficiency Virus Type 1 Integrase Are Not Required for Nuclear
Import of Proviral DNA
Caroline
Petit,1
Olivier
Schwartz,1 and
Fabrizio
Mammano2,*
Unité Rétrovirus et Transfert
Génétique, Institut Pasteur,1 and
Laboratoire de Recherche Antivirale, INSERM
U82,2 Paris, France
Received 5 January 2000/Accepted 2 May 2000
 |
ABSTRACT |
Integrase (IN) is a key component of the preintegration
nucleoprotein complex (PIC), which transports the retroviral genome from the cytoplasm to the nucleus of newly infected cells. Retroviral IN proteins have intrinsic karyophilic properties, which for human immunodeficiency virus type 1 (HIV-1) are currently attributed to
regions that display sequence homology to previously characterized nuclear localization signals. We asked here whether the karyophilic properties of HIV-1 IN are involved in the nuclear import of PIC. We
mutated three conserved basic regions in the C-terminal domain of IN
and analyzed the effects of mutations on subcellular localization of
the protein, viral particle composition, IN dimerization within virions, and infectivity. Alteration of two sequences caused the loss
of nuclear accumulation of IN and drastically reduced the capacity of
the protein to multimerize. Mutation of the most C-terminal sequence
had no effect on the subcellular localization and dimerization of IN.
Nevertheless, conservation of all three sequences was required for
viral infectivity. Despite the perturbation of IN subcellular localization, all mutant viruses displayed normal reverse transcription and nuclear transport of PICs in newly infected cells. The replicative defect was instead at the level of integration, for which all mutants
were markedly affected in vivo. Besides reinforcing the association
between dimerization of IN and nuclear accumulation of the enzyme, our
data demonstrate that subcellular localization of IN alone cannot
predict the fate of the PICs.
 |
INTRODUCTION |
The retroviral integrase (IN)
protein catalyzes integration of the provirus into a chromosome of the
infected cell, an essential step of the viral replication cycle (see
references 1 and 4 for recent reviews on
integration). IN is translated as part of the Gag-Pol precursor
molecule, which is cleaved by the viral protease to allow viral
particle maturation. Several in vitro studies have examined the
biochemical properties of IN, and significant progress has been made in
the understanding of its structure and of the mechanism of the
integration reaction (1, 4, 15, 31). IN catalyzes the two
steps of the integration process. The first step consists of the
elimination of 2 nucleotides from each 3' end of the proviral DNA. In
the second step, the resulting 3'-OH ends of the viral DNA are
covalently joined to newly created 5' ends in the target DNA (11,
18, 39).
Retroviral IN proteins are composed of three functionally distinct
domains (see Fig. 1A), all of which are required for a complete
integration reaction. The N-terminal domain contains a zinc finger-like
motif that stabilizes the folded structure of IN and enhances the
catalytic activity of the enzyme (57). The core domain of
retroviral IN contains the DDE motif to which the catalytic activity is
attributed. This central domain is also involved in the recognition of
the conserved nucleotide sequence at each end of the retroviral DNA.
The carboxy-terminal domain is the least conserved among retroviruses,
possesses intrinsic DNA binding activity, and is required for 3'-end
processing and strand transfer (10, 51). The functional form
of IN is multimeric, as was suggested by in vitro evidence of
multimerization and demonstrated by trans-complementation of
different IN mutants (16, 23, 34-36, 50). We recently
demonstrated that the multimerization of human immunodeficiency virus
type 1 (HIV-1) IN takes place in infectious viral particles and is
dependent on disulfide bond formation (46).
Besides the well characterized role in the integration process, IN
participates in different steps of the virus cycle. Alterations of IN
sequence were found to affect viral particle morphogenesis, reverse
transcription, and nuclear import of the preintegration complex (PIC)
(17, 28, 55), a nucleoprotein complex composed of viral and
probably cellular proteins that carries the viral genome from the
cytoplasm to the nucleus of the newly infected cell (9, 20, 21,
37, 38, 45).
HIV-1 IN has karyophilic properties which were demonstrated by the
nuclear accumulation of this protein both after transient expression of
a Flag- or green fluorescent protein-tagged IN (46, 47) and
after microinjection of HIV-1 IN fused to glutathione S-transferase (GST) (28). The GST-IN fusion
protein was additionally shown to bind in vitro to karyopherin-
(28), a cellular mediator of nuclear transport which is
specific for nuclear localization signal-bearing proteins. The
interaction between IN and karyopherin-
was suggested to be
functionally relevant in vivo, providing one additional mechanism for
the nuclear import of HIV-1 PIC (28). Participation of IN in
this process would be partially redundant with the functions proposed
for the viral proteins matrix and Vpr, which were suggested to be
implicated in the active transport of the PICs to the nuclei of resting
cells (8, 24, 28, 29, 32, 52), although some of these
reports remain disputed (5, 25, 27, 40). Besides viral
proteins, a cis-acting viral DNA structure, the DNA flap,
generated during lentivirus-specific reverse transcription, was
recently described as also playing an important role in the nuclear
import of the HIV-1 genome (56). Several sequences within
HIV-1 IN were pointed out as possible nuclear localization signals for
their high content of basic residues (28). Three such
motifs (186KRK, 211KELQKQITK, and
261PRRKAK) mapped in the C-terminal domain of HIV-1 IN,
deletion of which resulted in the loss of interaction with
karyopherin-
(28). These sequences were previously
highlighted as being conserved in lentiviruses, leading to the
suggestion that they may also be responsible for the ability of these
viruses to infect interphasic cells (12). The
186KRK tripeptide is part of a lentivirus-specific exposed
loop, called sequence L, which is absent in other retroviruses
(12, 15). The 211KELQKQITK motif falls within
the so-called glutamine-rich basic region of lentiviruses (sequence Q),
corresponding to the proline-rich region of oncoviruses
(12). Finally, the 261PRRKAK sequence is part of
the N region, for which the lentivirus consensus sequence clearly
differs from the oncovirus motif (12). It is important to
note, however that avian sarcoma virus IN was shown to readily
accumulate in the nucleus of transfected cells (41),
although this virus cannot infect nondividing cells.
In the present study we asked whether the karyophilic properties of
HIV-1 IN are required for nuclear import of PICs. We analyzed the
effect of mutations in the three above-described sequences both on the
karyophilic properties of HIV-1 IN expressed in the absence of other
viral proteins and on viral replication, with particular interest in
the nuclear import of viral PICs. Alteration of the sequences L and Q
separately or in combination resulted in the loss of nuclear
accumulation of HIV-1 IN, while wild-type and mutant IN molecules
carrying substitutions in the IN motif concentrated in the nucleus of
transfected cells. Nevertheless, alteration of each of the three
sequences resulted in the loss of viral replication. The inability of
the L- and Q-mutated IN proteins to accumulate in the nucleus was
associated with a markedly reduced capacity to dimerize in viral
particles. Most interestingly, for all four virus mutants the loss of
replicative capacity was due not to a deficient nuclear import of viral
DNA but to a defect in the integration process in vivo.
 |
MATERIALS AND METHODS |
Plasmid construction.
The Flag-INT vector, which allows the
expression of HIV-1 integrase fused to the Flag epitope at its N
terminus, has been described previously (46). Mutagenesis
was performed using the Quick-Change mutagenesis kit (Stratagene).
BRU-HA and BRU-Flag infectious molecular clones of HIV-1, which carry
an epitope-tagged IN (HA and Flag, respectively), have been described
previously (46). To obtain the BRU, BRU-HA, and BRU-Flag
full-length clones carrying mutated IN, the BspMI fragment
from the mutated Flag-INT vectors was used to replace the corresponding
sequence of the three clones. Constructions were confirmed by DNA
sequencing of the entire PCR-amplified fragment.
Cells, virus infection, and reagents.
Human epithelial HeLa,
P4 (HeLa-CD4+, LTR-LacZ) (13), and P4p56 (HeLa
CD4+, p56lck+, LTR-LacZ) cells were
grown in Dulbecco's modified Eagle's medium (Gibco) supplemented with
glutamine, antibiotics, and 10% fetal calf serum. P4 cells were grown
in the presence of G418 (1 mg/ml), and P4p56 cell medium was
supplemented with G418 and hygromycin (100 µg/ml). P4p56 cells were
used for measuring viral DNA synthesis and integration, since they
express higher levels of surface CD4 than do P4 cells and are more
susceptible to HIV infection. MT4 lymphoid cells were grown in RPMI
medium supplemented with glutamine, antibiotics, and 10% fetal calf
serum. Viruses were produced by transfection with the plasmids as
described previously (49). Supernatants were analyzed for
HIV-1 p24 antigen content by an enzyme-linked immunosorbent assay
(Dupont). P4 cells, plated in 96-well plates, were infected with
different viral doses. Infectivity was measured as previously described
(43). The anti-gag monoclonal antibodies (MAb) 25A (anti-CA)
and 18A (anti-MA) were a kind gift from François Traincart
(Institut Pasteur, Paris, France). The rabbit polyclonal anti-Flag
antibodies were from Zymed Laboratories (San Francisco, Calif.), and
the mouse anti-Flag MAb M2 was from Sigma. Cy3-conjugated anti-mouse
immunoglobulin G (heavy plus light chains) and peroxidase-conjugated
anti-mouse or anti-rabbit immunoglobulin G were from Amersham Life Science.
Indirect immunofluorescence staining.
HeLa cells (2 × 105) were spread on glass coverslips in 24-well plates,
transfected with the indicated plasmids, and stained for
immunofluorescence 24 to 40 h later. The cells were fixed in 3.7%
formaldehyde-phosphate-buffered saline (PBS) for 20 min, washed three
times in PBS, and incubated for 10 min in 50 mM NH4Cl to
quench free aldehydes. After one wash in PBS and a 15-min incubation in
permeabilization buffer (0.05% saponin, 0.01% Triton X-100, and 2%
bovine serum albumin in PBS), cells were incubated for 1 h with
the first Ab (M2 anti-Flag MAb) at 7.5 µg/ml in permeabilization buffer. The cells were then washed three times in permeabilization buffer and incubated with Cy3-conjugated anti-mouse Abs (Amersham) at a
final dilution of 1:200. The cells were washed three times in
permeabilization buffer and once in PBS and were mounted in 133 mg of
Mowiol (Hoechst) per ml-33% glycerol, 133 mM Tris HCl (pH 8.5).
Confocal microscopy was performed on a Leica TCS4D microscope. Series
of optical sections at 0.7-µm intervals were recorded. One
representative medial section was mounted using Adobe Photoshop software.
Western blot analysis.
Viral supernatants were collected
from transfected HeLa cells. Viruses were concentrated by
ultracentrifugation (15 min at 60,000 rpm in a Beckman TL100
centrifuge), and pellets were resuspended in lysis buffer (20 mM HEPES,
150 mM NaCl, 0.5% Triton). Proteins corresponding to 100 and 200 ng of
p24 were used for Gag and Flag analysis, respectively. Samples were
diluted in loading buffer in the absence or presence of dithiothreitol
(60 mM final concentration), boiled for 5 min, and analyzed by Western
blotting as previously described (46). Final concentrations
for each antibody were as follows: anti-gag 25A plus 18A, 0.5 µg/ml
each; rabbit anti-Flag, 2 µg/ml.
Analysis of viral DNA by Southern blotting.
P4p56 target
cells (12 × 106 per sample) were infected with
wild-type (WT) and mutated BRU-HA viruses adjusted for equivalent p24
concentration (2,500 ng in a final volume of 5 ml), in the presence of
20 µg of DEAE-dextran per ml. At 24 h after infection, low-molecular-weight DNA was prepared by Hirt extraction
(33). Samples were digested with DpnI to remove
residual plasmids that may contaminate viral supernatants and then with
EcoRI and subjected to Southern blot analysis. DNA from
approximately 4 × 106 target cells was analyzed in
each lane. The 32P-labeled DNA probe used for hybridization
was the 1.9-kb MscI fragment from the pol region
of pBRU. Total amounts of low-molecular-weight DNA were detected by
using a probe specific for the mitochondrial cytochrome b
gene. Gels were visualized by autoradiography and with a PhosphorImager.
Analysis of integrated viral DNA by PCR.
For the analysis of
integrated viral DNA, P4p56 cells were infected as described above and
total DNA was extracted, digested with DpnI, and subjected
to PCR using the method described by Chun et al. (14).
Briefly, 50 ng of total DNA was subjected to nested PCR, using for the
first round a 5' primer from the conserved human Alu sequence and a 3'
primer from the conserved HIV-1 long terminal repeat (LTR) sequence
(14). This round amplifies both cellular DNA upstream of the
integration site and integrated HIV-1 LTR. An aliquot (1/400) of the
first PCR product was subjected to the second round of PCR using nested
HIV-1 LTR-specific primers (14). In parallel, the presence
of total viral DNA was verified by performing the second round of PCR
directly on 50 ng of DNA sample. One-fifth of each PCR product was
analyzed by gel electrophoresis.
 |
RESULTS |
Subcellular localization of HIV-1 IN mutated in C-terminal basic
sequences.
Our first aim was to generate HIV-1 IN mutants with
altered karyophilic properties. The lentivirus-specific L, Q, and N
sequences were mutated in the Flag-INT expression vector. This vector
encoding HIV-1 IN fused to the Flag epitope allows the expression of IN in the absence of other viral proteins and its detection by
immunofluorescence staining (46). Two sets of mutations
shown to reduce the interaction of IN with karyopherin-
(28) were inserted: K186-Q in the lentivirus exposed loop L
(mutant IN-L) and the double glutamine substitution Q214-L Q216-L in
the lentivirus glutamine-rich sequence (mutant IN-Q) (Fig.
1A). Additionally, we reconstructed the
double mutation (IN-LQ) (Fig. 1A), which was previously reported to
abrogate the IN-karyopherin-
interaction (28). We also
asked whether the basic region N was involved in the karyophilic
properties of HIV-1 IN. To test this hypothesis, three basic residues
in the lentivirus consensus sequence N (262RRK) were
replaced by the corresponding residues of Moloney murine leukemia virus
(AAH, mutant IN-N).


View larger version (59K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation and intracellular localization
of WT and mutant IN. (A) Schematic representation of HIV-1 IN domains
and conserved basic regions that were altered by mutagenesis. Numbers
correspond to amino acid position of the IN domain of the BRU viral
clone. The L, Q, and N sequences were described previously as being
conserved in lentiviruses (12). (B) Confocal microscopy
analysis of WT and mutant (L, Q, LQ, and N) HIV-1 IN molecules. HeLa
cells were transfected with the Flag-INT plasmid expressing the WT or
mutant IN fused to the Flag epitope. Transfected cells were fixed,
permeabilized, and stained with anti-Flag antibodies. Series of optical
sections at 0.7-µm intervals were recorded. A representative medial
section is shown in panels marked IF (immunofluorescence). Panels IF+PC
represent a superimposition of IF staining and a phase-contrast image
of the same field. Bar, 15 µm.
|
|
As we previously demonstrated (
46), expression of WT HIV-1
IN in HeLa cells resulted in the almost exclusive nuclear localization
of IN (Fig.
1B), indicating active transport of IN. Alteration
of the
lentivirus L and Q sequence, either alone or in combination,
resulted
in the loss of nuclear accumulation of IN and a homogeneous
staining,
both in the nucleus and in the cytoplasm of the transfected
cells (Fig.
1B). This pattern suggests that IN molecules mutated
in the L and/or Q
sequence can freely diffuse through the nuclear
pores, as expected for
a protein of the size of monomeric IN (
22).
In contrast,
substitution of the charged HIV-1 tripeptide in the
N sequence with the
corresponding Moloney murine leukemia virus
residues resulted in a
staining profile indistinguishable from
that of WT IN (Fig.
1B). Thus,
the charged lentivirus consensus
of the N sequence is not required for
the nuclear accumulation
of HIV-1 IN and can be replaced by an
oncovirus sequence. Taken
together, our data show that the subcellular
localization of HIV-1
IN is markedly perturbed by alteration of the
conserved L and
Q sequences but not of the N
sequence.
Impact of mutations on virus infectivity and integrase
multimerization.
Given the proposed implication of IN in the
nuclear import of the PICs, we evaluated the impact of the
above-described mutations on the different steps of the viral cycle. We
inserted the IN mutations in the replication-competent molecular clone
pBRU, yielding L, Q, LQ, and N viruses. We then measured virus particle
production and infectivity of WT and mutant viruses. Gag p24 antigen
production, measured in the supernatant of HeLa cells transfected with
the different molecular clones, was similar for wild-type and mutant viruses (data not shown). Virus infectivity was monitored both by a
colorimetric test in a single-cycle infectivity assay using P4 (HeLa
CD4 LTR-LacZ) reporter cells and in a multiple-cycle assay using
T-lymphoid MT4 cells. As shown in Fig.
2A, the four mutant viruses were
noninfectious in both assays. Therefore, mutations in the L, Q, and N
sequences do not affect viral production, measured by p24 release in
the supernatant of virus-producing cells, but do abrogate viral
infectivity.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
Infectivity and protein content of viral particles
carrying WT and mutated IN. (A) WT and IN mutated pBRU clones were
transfected in HeLa cells. Viral particles released in the supernatant
of transfected cells were normalized for p24 content and used to infect
P4 (left) and MT4 (right) cells. Infectivity in P4 cells was tested in
a single-cycle assay, as previously described (43). N.I.,
noninfected cells. Replication in MT4 cells was assessed by p24
accumulation in the culture supernatant over a 10-day period. -gal,
-galactosidase; O.D., optical density. (B and C) HeLa cells were
transfected with pBRU molecular clone (lanes BRU) and with the isogenic
construct (pBRU-Flag molecular clone) in which IN was fused to the Flag
epitope and contains either WT (lanes WT) or mutated IN (lanes L, Q,
LQ, and N) sequences. Viral particles were harvested, concentrated by
ultracentrifugation, and analyzed by Western blotting with antibodies
specific for the HIV-1 gag matrix (p17) and capsid (p24) (B) or
specific for the Flag epitope (C) under reducing (+DTT) or nonreducing
( DTT) conditions. Proteins corresponding to 100 and 200 ng of p24
were used for Gag and Flag analysis, respectively. Molecular mass
markers are indicated on the left in kilodaltons.
|
|
We then analyzed the protein composition of viral particles and in
particular the multimeric status of IN. To this aim, the
IN mutants
were reconstructed in the replication-competent BRU-HA
and BRU-Flag
clones, in which IN is fused to a tagging epitope
(hemagglutinin and
the Flag peptide, respectively), allowing a
high sensitivity of
detection of IN by Western blotting (
46).
The protein
content of virions was analyzed by Western blotting
for the WT and IN
mutated BRU-Flag viral clones (Fig.
2B and C).
As previously described
(
46), IN epitope tagging did not alter
viral particle
production or Gag protein composition; accordingly,
BRU-Flag (Fig.
2B,
lane WT) displayed a Gag profile identical
to that of the original BRU
clone (Fig.
2B, lane BRU). Disruption
of the lentivirus-specific
sequences in mutants L, Q, LQ, and
N did not alter the Gag protein
profile (Fig.
2B). More interestingly,
we analyzed IN incorporation and
multimerization in viral particles
produced by WT and the corresponding
IN-mutated BRU-Flag viral
clones (Fig.
2C). We recently showed that
Western blot analysis
conducted under nonreducing conditions,
preserving disulfide bonds,
allowed the detection of IN multimers in
viral particles (
46).
Here we used the same approach to
detect and characterize mutated
IN molecules in viral particles. As
shown in Fig.
2C (left panel),
under reducing conditions WT and mutant
IN molecules were readily
detectable at similar levels. Mutants L and Q
displayed minor
IN specific degradation products (left panel),
indicating a reduced
stability of the mutated proteins. This phenotype
was enhanced
when the two mutations were present in the same IN
molecules (mutant
LQ, left panel). Mutant N, on the other hand,
displayed a WT protein
profile.
As we previously reported (
46), under nonreducing conditions
an additional IN-specific, strongly reactive signal with an
apparent
molecular mass of 70 kDa was observed in WT virions,
confirming that
disulfide bridges are required to form IN multimers.
The dimeric IN
signal was also observed with mutant N, indicating
that this mutant is
not affected in its ability to multimerize.
A slight reduction of the
signal corresponding to monomeric IN
was detected for mutants L and Q,
and the reduction was marked
for the double mutant LQ (Fig.
2C, right
panel). Since similar
amounts of WT and mutated IN are present in the
analyzed virions
(Fig.
2C, left panel), we concluded that the exposure
of the tagging
epitope was decreased under nonreducing conditions,
indicating
that IN mutants L, Q, and particularly LQ display structural
perturbation.
Moreover, the ratio of dimer to monomer signals was
strongly reduced
for mutants L and Q, while no signal corresponding to
IN multimers
was observed for the double mutant LQ (Fig.
2C, right
panel).
This result suggests that alteration of sequences L and Q is
detrimental
for IN dimerization. Of note, analysis of the particle
content
of mutant viral clones constructed in the BRU-HA context gave
similar results (data not shown), demonstrating that these observations
are independent of the tagging epitope. Also, it was previously
reported that IN mutants L and Q displayed reduced dimerization
in a
yeast two-hybrid system (
28), an observation that supports
our findings with viral
particles.
Taken together, these results strongly suggest that modification of
lentivirus-specific sequences L and Q induces conformational
changes of
IN molecules, which impair their ability to multimerize
and increase
their degradation in viral particles. The substitution
within the N
sequence did not appreciably alter IN conformation
or reduce the
dimerization potential of IN despite the sharp change
in the local
charge.
Mutant viruses display normal entry, DNA synthesis and nuclear
import of viral DNA.
The inability of IN-mutated viruses to induce
the expression of the reporter gene in P4 cells (Fig. 2A) indicates
that these mutants were affected in the early phases of the virus life
cycle. To determine precisely which step was implicated, we analyzed viral entry, synthesis and nuclear import of viral DNA, and integration into target cell DNA. We first examined whether mutations in the IN
sequence could influence viral entry by measuring the cytosolic HIV-1
p24 antigen content of newly infected P4 cells. Cytosolic p24 is a
reliable index of infectious events eventually leading to productive
infection (44). We did not observe a significant difference
between WT and mutant viruses (data not shown), indicating that the
entry step of the viral cycle is not affected by the mutations in IN.
We examined the reverse transcription and the nuclear import of
preintegrative viral DNA in newly infected P4p56 cells exposed
to WT or
mutant viruses adjusted to contain equivalent amounts
of p24.
Low-molecular-weight DNA was extracted by the Hirt procedure
24 h
after exposure of target cells to virion preparations and
was analyzed
by Southern blotting with a probe specific for the
pol gene.
Samples were digested by
EcoRI to produce diagnostic
fragments which discriminate the linear and circular forms of
viral DNA
(
2). As expected, after infection with wild-type
BRU virus,
two forms of circular viral DNA (containing one or
two LTRs) were
observed in addition to the linear form of the
genome (Fig.
3, top panel). No signal was detected
when target
cells were treated with azidothymidine or exposed to an
env-deleted
virus (data not shown), indicating that the DNA
detected by the
pol probe was the product of de novo
synthesis. Circular and linear
forms of viral DNA were instead observed
after infection of target
cells with IN mutant viruses (top panel). To
compare the reverse
transcription products of WT and mutant viruses, we
first needed
to measure the efficiency of DNA extraction. The total
amount
of cellular low-molecular-weight DNA present in cell extracts
was measured by hybridization of the same blot with a probe specific
for the mitochondrial cytochrome
b gene (Fig.
3, bottom
panel).
After correlation with the cytochrome
b signal, the
total (i.e.,
linear plus circular) amounts of viral DNA synthesized
during
the reverse transcription process were comparable for WT and IN
mutant viruses (Fig.
3, top panel). Therefore, all IN mutant viruses
analyzed here were competent for the synthesis of DNA genome of
the
expected size. Although this analysis does not provide precise
quantitative evaluation of the viral DNA content, it nevertheless
shows
that viral mutants L, Q, LQ, and N were competent for reverse
transcription.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 3.
Synthesis and circularization of viral DNA. P4p56 cells
were exposed to WT or IN-mutated (L, Q, LQ, and N) virions in amounts
adjusted to ensure equivalent levels of p24. At 24 h following
infection, low-molecular-weight DNA was prepared by Hirt extraction,
EcoRI digested and analyzed by Southern blotting with a
32P-labeled probe specific for the pol gene of
HIV-1 (top). Arrows indicate the circular and linear forms of viral
DNA. Hybridization of the same blot with a probe specific for the
mitochondrial cytochrome b gene (cyt. b) is shown
(bottom).
|
|
The linear form of viral DNA can be found in both the cytoplasm and the
nucleus of newly infected cells, while the circular
forms are generated
in the nucleus, probably by nuclear host enzymes
as an alternative
(dead end) to correct integration, and are commonly
used as markers for
nuclear import of the PICs (
3,
6,
19,
20,
38). The ratios of
circular to total (circular and linear)
forms of viral DNA were
equivalent for WT and mutant viruses (Fig.
3, top panel), indicating
that mutant viral DNA could access the
nuclear compartment with an
efficiency comparable to that of the
WT. Similar results were obtained
with BRU, BRU-HA, and BRU-Flag
viruses and with MT4 target cells or
when the analysis was performed
15 h after infection (data not
shown). Taken together, these results
demonstrated that viral DNA
molecules synthesized by WT and IN
mutant viruses gain access to the
nucleus in similar proportions.
Our findings are in agreement with
previous reports showing by
a different technique that mutants L and Q
were not affected in
the nuclear import of proviral DNA in dividing or
in nondividing
cells (
12,
28). Therefore, we conclude that
the nuclear import
of PICs was not affected in L, Q, LQ, and N mutant
viruses.
Mutant viruses are impaired in the integration process.
Once
we determined that virions carrying mutations in the L, Q, and N
sequences performed the nuclear import of PICs efficiently, we analyzed
the capacity of these mutants to integrate proviral DNA into the host
genome. P4p56 cells were exposed for 24 h to WT and IN mutant
viruses adjusted to contain equivalent amounts of p24, and DNA was
extracted to determine the amount of total and integrated viral DNA.
The total viral DNA was amplified with primers specific for the HIV-1
LTR sequence and was found to be at least as abundant in cells exposed
to the four mutant viruses as in cells infected by the WT virus (Fig.
4, bottom panel). This finding is in
agreement with our observation of normal synthesis of viral DNA in the
IN mutant viruses, obtained by Southern blotting analysis of viral DNA
without a PCR step (Fig. 3). We then analyzed integrated proviral DNA
by the Alu-LTR PCR technique (14). The boundary of host and
viral DNA was amplified in a first PCR using a primer specific for the
human Alu sequence and a primer complementary to the viral 5' LTR. An
aliquot of this reaction product was further amplified using nested HIV
LTR-specific primers. A strong signal was observed with WT virus (Fig.
4, top panel), confirming that integrated DNA can be efficiently
detected in this experimental setting. Under the same conditions, cells
exposed to mutants L, Q, LQ, and N produced barely detectable signals
(top panel), indicating that the four replication-defective IN mutants
were markedly affected at the integration step. The weak signal
observed with IN mutants could represent residual integration activity
but could also be due to aberrant or HIV-1 IN-independent integration
products previously observed with IN mutants (30). Such
drastic reduction of integrated viral DNA observed for the IN mutated
viruses in vivo, combined with our data on normal nuclear import of
viral DNA, supports the interpretation that the lack of infectivity is
due to a direct effect on IN enzymatic properties including viral DNA
binding, processing, and insertion rather than to defective nuclear
import of viral PICs.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
Integration of viral DNA. P4p56 cells were exposed to WT
or IN-mutated (L, Q, LQ, and N) virions in amounts adjusted to ensure
equivalent levels of p24. At 24 h following infection, DNA was
prepared and analyzed by PCR to visualize integrated and total viral
DNA. Integrated viral DNA (top) was amplified by nested PCR. In the
first round of PCR, a 5' primer from the conserved human Alu sequence
and a 3' primer from the conserved HIV-1 LTR sequence were used. This
round amplifies both cellular DNA upstream of the integration site and
integrated HIV-1 LTR. An aliquot (1/400) of the first PCR product was
further subjected to the second round of PCR by using nested HIV-1
LTR-specific primers. To verify that only integrated viral DNA was
amplified by the two-round procedure, control reactions (including the
1/400 dilution step) were performed in which the primers and the enzyme
were omitted in the first PCR (not shown). Total viral DNA (bottom) was
amplified using primers from the HIV-1 LTR sequence. Mock-infected
cells were similarly analyzed as a negative control (lane CTRL).
|
|
 |
DISCUSSION |
We and others have previously shown that HIV-1 IN has intrinsic
karyophilic properties, since it accumulates in the nuclear compartment
when expressed in the absence of other viral proteins (28, 46,
47). To alter the subcellular localization of IN, we mutated the
three C-terminal basic sequences, L, Q, and N. We first examined the
subcellular distribution of IN mutated in basic motifs (L and Q) that
were proposed to act as NLS (28). We observed that in
contrast to the WT protein, which accumulated in the nucleus, IN
proteins mutated in the L or Q sequence and the double LQ mutant
displayed a homogenous distribution, both in the nucleus and in the
cytosol, indicating that these mutations affected the karyophilic
properties of IN. Similarly, IN fused to GST and microinjected into the
cytoplasm of Cos cells was found to display an almost exclusive nuclear
localization while IN mutants L and Q in this context failed to
localize to the nucleus (28). The finding that these
mutations prevented the nuclear import of IN in the context of a large
fusion protein (IN-GST) suggests that the residual nuclear staining we
observed when IN was fused to a small Flag epitope was the consequence
of passive diffusion through nuclear pores.
Besides the loss of nuclear accumulation of IN, alteration of the L and
Q sequences induced other phenotypes. We observed a drastic reduction
of IN multimers in viral particles, associated with an increased
degradation of the protein. Moreover, under nonreducing conditions, IN
mutants were less well recognized by anti-Tag antibodies. Altogether,
these results strongly suggest that the overall conformation of IN
mutants L, Q, and LQ was markedly affected. It should be pointed out
that perturbation of the subcellular localization of IN by mutations
does not imply that the targeted sequences are NLS (25). A
structural perturbation imposed by the mutations could in fact impair
the exposure of a distal NLS. In this respect, we previously reported
the loss of nuclear accumulation associated with the IN mutation
C130-G, a position that is not part of any NLS-like sequence
(46). The loss of karyophilic properties was attributed for
this mutant to the significant alteration of IN structure. A similar
distal effect could also be responsible for the previously reported
loss of the karyopherin-
in vitro binding activity of IN mutant LQ
(28).
It is interesting to note that the loss of nuclear accumulation in
mutants L, Q, and LQ was associated with a drastic reduction of the
multimerization of IN in viral particles. We previously observed that
the two phenotypes were also associated for the mutation C130-G
(46). Accordingly, alteration of the N sequence, although
lethal for the virus, did not impair nuclear localization or
dimerization of IN. One can therefore speculate that dimerization of IN
favors nuclear accumulation of the protein, possibly by allowing
interaction with host proteins or DNA. After penetration in the
cytoplasm of a target cell, specific viral components need to gain
access to the nucleus. How retroviruses manage to reach this
compartment is not fully understood. Lentiviruses in particular are
even more complex than other retroviruses, being able to infect both
dividing and nondividing cells (8, 42, 54). Whether they use
different mechanisms to gain access to the nucleus depending on the
replicative status of target cells is unknown. The requirement for
specific sequences in the matrix, Vpr, and IN proteins to infect
differentiated or growth-arrested cells in tissue culture was proposed
by some authors but discounted by others (7, 8, 24-29, 32).
In particular, HIV-1 IN has been proposed to participate in the nuclear
import of PICs in nonproliferating cells by recruiting phosphorylated
matrix proteins to the core of the PICs and by interacting with
karyopherin-
(28, 29). The relevance of karyophilic
properties of lentivirus IN for infection of interphasic cells can,
however, be challenged by the finding that oncovirus IN proteins have
comparable karyophilic characteristics (41).
We have analyzed the different steps of virus replication for HIV-1
mutants carrying karyophilic IN proteins (viruses WT and N) and
nonkaryophilic ones (L, Q, and LQ), with particular interest in the
nuclear import of PICs. Our results demonstrate that conservation of
the L, Q, and N sequences is required for viral infectivity. Alteration
of these motifs was, however, compatible with viral particle formation,
target cell entry, and viral DNA synthesis and did not impair nuclear
transport of viral DNA. It is clear from these results that one cannot
determine the fate of the PICs on the basis of the localization of IN
protein expressed alone. Besides, nuclear import of viral DNA does not
appear to require the karyophilic potential of IN, since it takes place
with normal efficiency in the presence of IN molecules that are unable
to accumulate in the nuclear compartment. Instead, we observed a drastic reduction of integrated viral DNA for the IN-mutated viruses in
vivo, indicating that the lack of infectivity was due to a direct
effect on IN enzymatic properties. Accordingly, normal nuclear import
of viral PICs for mutants L and Q was reported independently of the
replicative status of target cells (12, 28). Gallay et al.
proposed a complex interpretation of their results to take into account
their observation of reduced in vitro binding to karyopherins observed
with mutated IN (28). These authors acknowledged that
mutants L and Q were unable to replicate due to a block in integration,
independently of the replicative status of target cells, but in
addition suggested that in nondividing cells the recruitment of PICs by
karyopherins might be inefficient due to mutations in IN
(28). Our results support the simpler view that a defective
integration process is the cause of the lack of replication of these
mutant viruses in both dividing and nondividing cells.
It would be interesting to know whether the mutated IN proteins studied
here could still associate with viral DNA and enter the nucleus as part
of the PICs. Although the association between viral DNA and IN takes
place early after reverse transcription, probably while the DNA is
still in the cytoplasm (20, 45, 48, 53), we cannot exclude
the possibility that viral DNA of IN mutants entered the nucleus
independently of IN, as part of abortive PICs. An attempt to detect IN
molecules in the nuclei of newly infected cells by immunofluorescence
staining did not give definitive results (data not shown).
Impaired enzymatic activity of IN mutants L, Q, and LQ was not totally
unexpected, given the structural perturbation of the proteins, which
also had major repercussion on their dimerization and karyophilic
properties. Mutant N instead appears to be specifically affected at the
integration step, since IN structure, dimerization, and karyophilic
properties were preserved and all the analyzed steps of the viral cycle
were performed with WT efficiency. This mutant provides a useful tool
for studies of the integration process in a cellular context, since
other mutations in IN were shown to have pleiotropic effects (17,
55).
In conclusion, our data demonstrate that alteration of the L and Q
sequences affects the karyophilic properties of HIV-1 IN but not those
of viral PICs. Rather, conservation of the L, Q, and N sequences is
required for efficient integration in vivo. The diverse effects of
mutations on IN properties are most probably due to structural
perturbation of this enzyme. In the virus context, a possible role of
IN for nuclear import of PICs may be indirect, such as a structural
determinant allowing the correct architecture of the complex, and
should not depend on IN karyophilic properties.
 |
ACKNOWLEDGMENTS |
We thank Jean Michel Heard and François Clavel for support
and critical suggestions. We thank Guillermina Bolcini and Elisabeth Menu for helpful advice on the Alu-LTR PCR technique. We thank Emmanuelle Perret for confocal microscopy analysis, Virginie Trouplin for help with cloning, and François Traincart for the kind gift of reagents.
C.P. is a fellow of Agence Nationale de Recherche sur le SIDA (ANRS).
This work was supported by grants from the ANRS, SIDACTION, and the
Pasteur Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Recherche Antivirale, IMEA/INSERM Hôpital Bichat-Claude Bernard,
46 rue H. Huchard, 75018 Paris, France. Phone: 33-1-4025 6359. Fax: 33-1-4025 6370. E-mail: mammano{at}bichat.inserm.fr.
 |
REFERENCES |
| 1.
|
Asante-Appiah, E., and A. M. Skalka.
1997.
Molecular mechanisms in retrovirus DNA integration.
Antiviral Res.
36:139-156[CrossRef][Medline].
|
| 2.
|
Barbosa, P.,
P. Charneau,
N. Dumey, and F. Clavel.
1994.
Kinetic analysis of HIV-1 early replicative steps in a coculture system.
AIDS Res. Hum. Retroviruses
10:53-59[Medline].
|
| 3.
|
Bowerman, B.,
P. O. Brown,
J. M. Bishop, and H. E. Varmus.
1989.
A nucleoprotein complex mediates the integration of retroviral DNA.
Genes Dev.
3:469-478[Abstract/Free Full Text].
|
| 4.
|
Brown, P. O.
1997.
Integration, p. 161-204.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
|
| 5.
|
Bukrinskaya, A. G.,
A. Ghorpade,
N. K. Heinzinger,
T. E. Smithgall,
R. E. Lewis, and M. Stevenson.
1996.
Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.
Proc. Natl. Acad. Sci. USA
93:367-371[Abstract/Free Full Text].
|
| 6.
|
Bukrinsky, M.,
N. Sharova, and M. Stevenson.
1993.
Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex.
J. Virol.
67:6863-6865[Abstract/Free Full Text].
|
| 7.
|
Bukrinsky, M. I., and O. K. Haffar.
1998.
HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr.
Mol. Med.
4:138-143[Medline].
|
| 8.
|
Bukrinsky, M. I.,
S. Haggerty,
M. P. Dempsey,
N. Sharova,
A. Adzhubei,
L. Spitz,
P. Lewis,
D. Goldfarb,
M. Emerman, and M. Stevenson.
1993.
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.
Nature
365:666-669[CrossRef][Medline].
|
| 9.
|
Bukrinsky, M. I.,
N. Sharova,
T. L. McDonald,
T. Pushkarskaya,
W. G. Tarpley, and M. Stevenson.
1993.
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.
Proc. Natl. Acad. Sci. USA
90:6125-6129[Abstract/Free Full Text].
|
| 10.
|
Bushman, F. D.,
A. Engelman,
I. Palmer,
P. Wingfield, and R. Craigie.
1993.
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding.
Proc. Natl. Acad. Sci. USA
90:3428-3432[Abstract/Free Full Text].
|
| 11.
|
Bushman, F. D.,
T. Fujiwara, and R. Craigie.
1990.
Retroviral DNA integration directed by HIV integration protein in vitro.
Science
249:1555-1558[Abstract/Free Full Text].
|
| 12.
|
Cannon, P. M.,
E. D. Byles,
S. M. Kingsman, and A. J. Kingsman.
1996.
Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication.
J. Virol.
70:651-657[Abstract].
|
| 13.
|
Charneau, P.,
G. Mirabeau,
P. Roux,
S. Paulous,
H. Buc, and F. Clavel.
1994.
HIV-1 reverse transcription: a termination step at the center of the genome.
J. Mol. Biol.
241:651-662[CrossRef][Medline].
|
| 14.
|
Chun, T. W.,
L. Stuyver,
S. B. Mizell,
L. A. Ehler,
J. A. Mican,
M. Baseler,
A. L. Lloyd,
M. A. Nowak, and A. S. Fauci.
1997.
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
Proc. Natl. Acad. Sci. USA
94:13193-13197[Abstract/Free Full Text].
|
| 15.
|
Dyda, F.,
A. B. Hickman,
T. M. Jenkins,
A. Engelman,
R. Craigie, and D. R. Davies.
1994.
Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.
Science
266:1981-1986[Abstract/Free Full Text].
|
| 16.
|
Engelman, A.,
F. D. Bushman, and R. Craigie.
1993.
Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex.
EMBO J.
12:3269-3275[Medline].
|
| 17.
|
Engelman, A.,
G. Englund,
J. M. Orenstein,
M. A. Martin, and R. Craigie.
1995.
Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
J. Virol.
69:2729-2736[Abstract].
|
| 18.
|
Engelman, A.,
K. Mizuuchi, and R. Craigie.
1991.
HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer.
Cell
67:1211-1221[CrossRef][Medline].
|
| 19.
|
Farnet, C., and W. A. Haseltine.
1991.
Circularization of human immunodeficiency virus type 1 DNA in vitro.
J. Virol.
65:6942-6952[Abstract/Free Full Text].
|
| 20.
|
Farnet, C., and W. A. Haseltine.
1991.
Determination of viral proteins present in the Human Immunodeficiency Virus type 1 preintegration complex.
J. Virol.
65:1910-1915[Abstract/Free Full Text].
|
| 21.
|
Farnet, C. M., and F. D. Bushman.
1997.
HIV-1 cDNA integration requirement of HMG I(Y) protein for function of preintegration complexes in vitro.
Cell
88:483-492[CrossRef][Medline].
|
| 22.
|
Finlay, D. R., and D. J. Forbes.
1990.
Reconstitution of biochemically altered nuclear pores: transport can be eliminated and restored.
Cell
60:17-29[CrossRef][Medline].
|
| 23.
|
Fletcher, T. M.,
M. A. Soares,
S. McPhearson,
H. X. Hui,
M. A. Wiskerchen,
M. A. Muesing,
G. M. Shaw,
A. D. Leavitt,
J. D. Boeke, and B. H. Hahn.
1997.
Complementation of integrase function in HIV-1 virions.
EMBO J.
16:5123-5138[CrossRef][Medline].
|
| 24.
|
Fouchier, R. A.,
B. E. Meyer,
J. H. Simon,
U. Fischer,
A. V. Albright,
F. Gonzalez-Scarano, and M. H. Malim.
1998.
Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.
J. Virol.
72:6004-6013[Abstract/Free Full Text].
|
| 25.
|
Fouchier, R. A.,
B. E. Meyer,
J. H. Simon,
U. Fischer, and M. H. Malim.
1997.
HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.
EMBO J.
16:4531-4539[CrossRef][Medline].
|
| 26.
|
Freed, E.,
G. Englund,
F. Maldarelli, and M. A. Martin.
1997.
Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection.
Cell
88:171-174[CrossRef][Medline].
|
| 27.
|
Freed, E. O., and M. Martin.
1994.
HIV-1 infection of non-dividing cells.
Nature
369:107-108[Medline].
|
| 28.
|
Gallay, P.,
T. Hope,
D. Chin, and D. Trono.
1997.
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.
Proc. Natl. Acad. Sci. USA
94:9825-9830[Abstract/Free Full Text].
|
| 29.
|
Gallay, P.,
S. Swingler,
J. Song,
F. Bushman, and D. Trono.
1995.
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase.
Cell
83:569-576[CrossRef][Medline].
|
| 30.
|
Gaur, M., and A. D. Leavitt.
1998.
Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation.
J. Virol.
72:4678-4685[Abstract/Free Full Text].
|
| 31.
|
Goodarzi, G.,
G. J. Im,
K. Brackmann, and D. Grandgenett.
1995.
Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase.
J. Virol.
69:6090-6097[Abstract].
|
| 32.
|
Heinzinger, N. K.,
M. I. Bukrinsky,
S. A. Haggerty,
A. M. Ragland,
V. Kewalramani,
M. A. Lee,
H. E. Gendelman,
L. Ratner,
M. Stevenson, and M. Emerman.
1994.
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.
Proc. Natl. Acad. Sci. USA
91:7311-7315[Abstract/Free Full Text].
|
| 33.
|
Hirt, B.
1967.
Selective extraction of polyoma DNA from infected mouse cell cultures.
J. Mol. Biol.
26:365-369[CrossRef][Medline].
|
| 34.
|
Jenkins, T. M.,
A. Engelman,
R. Ghirlando, and R. Craigie.
1996.
A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization.
J. Biol. Chem.
271:7712-7718[Abstract/Free Full Text].
|
| 35.
|
Jones, K. S.,
J. Coleman,
G. W. Merkel,
T. M. Laue, and A. M. Skalka.
1992.
Retroviral integrase functions as a multimer and can turn over catalytically.
J. Biol. Chem.
267:16037-16040[Abstract/Free Full Text].
|
| 36.
|
Kalpana, G. V., and S. P. Goff.
1993.
Genetic analysis of homomeric interactions of human immunodeficiency virus type 1 integrase using the yeast two-hybrid system.
Proc. Natl. Acad. Sci. USA
90:10593-10597[Abstract/Free Full Text].
|
| 37.
|
Kalpana, G. V.,
S. Marmon,
W. Wang,
G. R. Crabtree, and S. P. Goff.
1994.
Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.
Science
266:2002-2006[Abstract/Free Full Text].
|
| 38.
|
Karageorgos, L.,
P. Li, and C. Burrell.
1993.
Characterization of HIV replication complexes early after cell-to-cell infection.
AIDS Res. Hum. Retroviruses
9:817-823[Medline].
|
| 39.
|
Katzman, M.,
J. P. Mack,
A. M. Skalka, and J. Leis.
1991.
A covalent complex between retroviral integrase and nicked substrate DNA.
Proc. Natl. Acad. Sci. USA
88:4695-4699[Abstract/Free Full Text].
|
| 40.
|
Kootstra, N. A., and H. Schuitemaker.
1999.
Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.
Virology
253:170-180[CrossRef][Medline].
|
| 41.
|
Kukolj, G.,
K. S. Jones, and A. M. Skalka.
1997.
Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases.
J. Virol.
71:843-847[Abstract].
|
| 42.
|
Lewis, P., and M. Emerman.
1994.
Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.
J. Virol.
68:510-516[Abstract/Free Full Text].
|
| 43.
|
Mammano, F.,
C. Petit, and F. Clavel.
1998.
Resistance-associated loss of viral fitness in human immunodeficiency virus: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients.
J. Virol.
72:7632-7637[Abstract/Free Full Text].
|
| 44.
|
Maréchal, V.,
F. Clavel,
J. M. Heard, and O. Schwartz.
1998.
Cytosolic Gag p24 as an index of HIV-1 productive entry.
J. Virol.
72:2208-2212[Abstract/Free Full Text].
|
| 45.
|
Miller, M. D.,
C. M. Farnet, and F. D. Bushman.
1997.
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.
J. Virol.
71:5382-5390[Abstract].
|
| 46.
|
Petit, C.,
O. Schwartz, and F. Mammano.
1999.
Oligomerization within virions and subcellular localization of human immunodeficiency virus type 1 integrase.
J. Virol.
73:5079-5088[Abstract/Free Full Text].
|
| 47.
|
Pluymers, W.,
P. Cherepanov,
D. Schols,
E. De Clercq, and Z. Debyser.
1999.
Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein.
Virology
258:327-332[CrossRef][Medline].
|
| 48.
|
Roth, M.,
P. Schwartzberg, and S. P. Goff.
1989.
Structure of the termini of DNA intermediates in the integration of retroviral DNA.
Cell
58:47-54[CrossRef][Medline].
|
| 49.
|
Schwartz, O.,
V. Maréchal,
O. Danos, and J. M. Heard.
1995b.
Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell.
J. Virol.
69:4053-4059[Abstract].
|
| 50.
|
van Gent, D. C.,
C. Vink,
A. A. Groeneger, and R. H. Plasterk.
1993.
Complementation between HIV integrase proteins mutated in different domains.
EMBO J.
12:3261-3267[Medline].
|
| 51.
|
Vink, C.,
A. M. Oude Groeneger, and R. H. Plasterk.
1993.
Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type 1 integrase protein.
Nucleic Acids Res.
21:1419-1425[Abstract/Free Full Text].
|
| 52.
|
von Schwedler, U.,
R. S. Kornblut, and D. Trono.
1994.
The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes.
Proc. Natl. Acad. Sci. USA
91:6992-6996[Abstract/Free Full Text].
|
| 53.
|
Wei, S. Q.,
K. Mizuuchi, and R. Craigie.
1997.
A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration.
EMBO J.
16:7511-7520[CrossRef][Medline].
|
| 54.
|
Weinberg, J. B.,
T. J. Matthews,
B. R. Cullen, and M. H. Malim.
1991.
Productive human immunodeficiency virus type 1 (HIV-1) infection of non proliferative human monocytes.
J. Exp. Med.
88:1477-1482.
|
| 55.
|
Wu, X.,
H. Liu,
H. Xiao,
J. A. Conway,
E. Hehl,
G. V. Kalpana,
V. Prasad, and J. C. Kappes.
1999.
Human Immunodeficiency Virus type 1 Integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.
J. Virol.
73:2126-2135[Abstract/Free Full Text].
|
| 56.
|
Zennou, V.,
C. Petit,
D. Guetard,
U. Nerhbass,
L. Montagnier, and P. Charneau.
2000.
HIV-1 genome nuclear import is mediated by a central DNA flap.
Cell
101:173-185[CrossRef][Medline].
|
| 57.
|
Zheng, R. L.,
T. M. Jenkins, and R. Craigie.
1996.
Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity.
Proc. Natl. Acad. Sci. USA
93:13659-13664[Abstract/Free Full Text].
|
Journal of Virology, August 2000, p. 7119-7126, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
McKee, C. J., Kessl, J. J., Shkriabai, N., Dar, M. J., Engelman, A., Kvaratskhelia, M.
(2008). Dynamic Modulation of HIV-1 Integrase Structure and Function by Cellular Lens Epithelium-derived Growth Factor (LEDGF) Protein. J. Biol. Chem.
283: 31802-31812
[Abstract]
[Full Text]
-
Ao, Z., Huang, G., Yao, H., Xu, Z., Labine, M., Cochrane, A. W., Yao, X.
(2007). Interaction of Human Immunodeficiency Virus Type 1 Integrase with Cellular Nuclear Import Receptor Importin 7 and Its Impact on Viral Replication. J. Biol. Chem.
282: 13456-13467
[Abstract]
[Full Text]
-
Tsurutani, N., Yasuda, J., Yamamoto, N., Choi, B.-I., Kadoki, M., Iwakura, Y.
(2007). Nuclear Import of the Preintegration Complex Is Blocked upon Infection by Human Immunodeficiency Virus Type 1 in Mouse Cells. J. Virol.
81: 677-688
[Abstract]
[Full Text]
-
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., Serguera, C.
(2006). Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl. Acad. Sci. USA
103: 17684-17689
[Abstract]
[Full Text]
-
Arhel, N., Munier, S., Souque, P., Mollier, K., Charneau, P.
(2006). Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type.. J. Virol.
80: 10262-10269
[Abstract]
[Full Text]
-
Lu, R., Ghory, H. Z., Engelman, A.
(2005). Genetic Analyses of Conserved Residues in the Carboxyl-Terminal Domain of Human Immunodeficiency Virus Type 1 Integrase. J. Virol.
79: 10356-10368
[Abstract]
[Full Text]
-
Jin, S., Chen, C., Montelaro, R. C.
(2005). Equine Infectious Anemia Virus Gag p9 Function in Early Steps of Virus Infection and Provirus Production. J. Virol.
79: 8793-8801
[Abstract]
[Full Text]
-
Vanegas, M., Llano, M., Delgado, S., Thompson, D., Peretz, M., Poeschla, E.
(2005). Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J. Cell Sci.
118: 1733-1743
[Abstract]
[Full Text]
-
Llano, M., Delgado, S., Vanegas, M., Poeschla, E. M.
(2004). Lens Epithelium-derived Growth Factor/p75 Prevents Proteasomal Degradation of HIV-1 Integrase. J. Biol. Chem.
279: 55570-55577
[Abstract]
[Full Text]
-
Lu, R., Limon, A., Devroe, E., Silver, P. A., Cherepanov, P., Engelman, A.
(2004). Class II Integrase Mutants with Changes in Putative Nuclear Localization Signals Are Primarily Blocked at a Postnuclear Entry Step of Human Immunodeficiency Virus Type 1 Replication. J. Virol.
78: 12735-12746
[Abstract]
[Full Text]
-
Ikeda, T., Nishitsuji, H., Zhou, X., Nara, N., Ohashi, T., Kannagi, M., Masuda, T.
(2004). Evaluation of the Functional Involvement of Human Immunodeficiency Virus Type 1 Integrase in Nuclear Import of Viral cDNA during Acute Infection. J. Virol.
78: 11563-11573
[Abstract]
[Full Text]
-
Mousnier, A., Leh, H., Mouscadet, J.-F., Dargemont, C.
(2004). Nuclear Import of HIV-1 Integrase Is Inhibited in Vitro by Styrylquinoline Derivatives. Mol. Pharmacol.
66: 783-788
[Abstract]
[Full Text]
-
Llano, M., Vanegas, M., Fregoso, O., Saenz, D., Chung, S., Peretz, M., Poeschla, E. M.
(2004). LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes. J. Virol.
78: 9524-9537
[Abstract]
[Full Text]
-
Yamashita, M., Emerman, M.
(2004). Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells. J. Virol.
78: 5670-5678
[Abstract]
[Full Text]
-
Ao, Z., Yao, X., Cohen, E. A.
(2004). Assessment of the Role of the Central DNA Flap in Human Immunodeficiency Virus Type 1 Replication by Using a Single-Cycle Replication System. J. Virol.
78: 3170-3177
[Abstract]
[Full Text]
-
Violot, S., Hong, S. S., Rakotobe, D., Petit, C., Gay, B., Moreau, K., Billaud, G., Priet, S., Sire, J., Schwartz, O., Mouscadet, J.-F., Boulanger, P.
(2003). The Human Polycomb Group EED Protein Interacts with the Integrase of Human Immunodeficiency Virus Type 1. J. Virol.
77: 12507-12522
[Abstract]
[Full Text]
-
Devroe, E., Engelman, A., Silver, P. A.
(2003). Intracellular transport of human immunodeficiency virus type 1 integrase. J. Cell Sci.
116: 4401-4408
[Abstract]
[Full Text]
-
Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., Engelborghs, Y.
(2003). LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells. J. Biol. Chem.
278: 33528-33539
[Abstract]
[Full Text]
-
Woodward, C. L., Wang, Y., Dixon, W. J., Htun, H., Chow, S. A.
(2003). Subcellular Localization of Feline Immunodeficiency Virus Integrase and Mapping of Its Karyophilic Determinant. J. Virol.
77: 4516-4527
[Abstract]
[Full Text]
-
Eckstein, D. A., Sherman, M. P., Penn, M. L., Chin, P. S., De Noronha, C. M.C., Greene, W. C., Goldsmith, M. A.
(2001). HIV-1 Vpr Enhances Viral Burden by Facilitating Infection of Tissue Macrophages but Not Nondividing CD4+ T Cells. JEM
194: 1407-1419
[Abstract]
[Full Text]
-
Depienne, C., Mousnier, A., Leh, H., Le Rouzic, E., Dormont, D., Benichou, S., Dargemont, C.
(2001). Characterization of the Nuclear Import Pathway for HIV-1 Integrase. J. Biol. Chem.
276: 18102-18107
[Abstract]
[Full Text]